United Therapeutics Corp

NASDAQ:UTHR  
295.52
-4.64 (-1.55%)
5:23:33 PM EDT: $295.52 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.12B
Current PE10.84
Forward PE 10.6
2yr Forward PE 10.07
See more stats
Estimates Current Quarter
Revenue$804.98 Million
Adjusted EPS$7.35
See more estimates
10-Day MA$294.61
50-Day MA$301.05
200-Day MA$335.24
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.